Axalta Coating Systems Ltd.

Fundamentals7.0
Price Action6.5
News Sentiment6.5
AI Rating
6.8

Key Drivers

  • Margin stability
  • Liquidity pressure
  • Moderate valuation

AI
AI Summary

6.8

AXTA should now be viewed primarily as a merger-driven execution story rather than a pure coatings name: the AkzoNobel deal could unlock meaningful scale and earnings accretion, but with the stock already rerated and valuation no longer cheap, the key risk is whether management can deliver synergies and integration cleanly enough to justify the move.

Merger
IntegrationRisk
Valuation‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Margin stability
  • Liquidity pressure
  • Moderate valuation

AXTA maintains solid margins and free cash flow with improving debt metrics, but weaker liquidity and only mid-range valuation temper the investment case.

StableMargins
LiquidityRisk

Price Behavior

6.5
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher-low trend
  • Breakout holding
  • Stretched near highs

AXTA is in a constructive last-month uptrend, holding above its breakout zone and higher lows, but the move to $38.19 leaves it stretched and vulnerable to a pause or pullback toward $36.0–$36.3.

uptrend
neutral
Support Level: $36.0–$36.3
Resistance Level: $38.19

Quick run from $32.34 to $37.31 over the last month suggests momentum is strong but may be due for consolidation

Sentiment & News

6.5

Key News Insights:

  • Record EBITDA
  • Merger approved
  • Valuation focus

Axalta posted a strong Q2 with record EBITDA, lower leverage, and an unchanged 2026 outlook, while merger approval and mixed valuation signals kept the stock focused on execution and relative value. #M&A‍

Earnings

Strong operating results and merger momentum are supportive for AXTA, but upside may be tempered by valuation concerns and ongoing macro cost risks